Unicentric Form of Castleman Disease - Surgery Therapy Benefit

Surgery Clinical Trial

Official title:

Castleman Disease - Diagnosis and Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05440305
• Other study ID #: 750923
• Status: Completed
• Start date: January 1, 2011
• Est. completion date: April 30, 2022

Study information

• Verified date: June 2022
• Source: Charles University, Czech Republic
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Observation study on patients with unicentric form of Castleman disease, evaluation of surgical treatment benefit. Observation of surgical treatment strategy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: April 30, 2022
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• patient with unicentric form of Castleman disease
• underwent surgery resection

Exclusion Criteria:

• multilocalised Castleman disease

Related Conditions & MeSH terms

• Castleman Disease
• Surgery

Intervention

Procedure:
• surgery type/exstirpation/debulking
Evaluation of benefit according to surgery

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Charles University, Czech Republic

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	5 year survival	surgery treatment success	each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression
Primary	recurence rate	surgery treatment success	each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression